Prescription Opioid Misuse: Effective Methods for Reducing the Epidemic

被引:0
|
作者
Li X. [1 ,3 ]
Shorter D. [2 ,3 ]
Kosten T. [2 ,3 ]
机构
[1] Harris Health - Ben Taub General Hospital, 1504 Taub Loop, Houston, 77030, TX
[2] Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd, Houston, 77030, TX
[3] Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, One Baylor Plaza, Houston, 77030, TX
关键词
Abuse-deterrent formulations; Buprenorphine; Oxycodone; Prescription opioid abuse;
D O I
10.1007/s40501-015-0045-6
中图分类号
学科分类号
摘要
Prescription opioid misuse has been a significant epidemic during the past decade. Formulations of prescription opioids with different mechanisms of abuse-deterrence have been developed or are currently under development. Given that these medications are substantially more difficult to use in an illicit fashion and minimize the potential for euphoria and/or create an aversive experience when over-ingested, they represent an important next step in pharmacological innovation. Immediate decreases in nonmedical use and in associated overdose mortality and adverse events have been observed after a highly abused opioid, OxyContin, was changed into an abuse-deterrent formulation. However, this reduction in OxyContin use may have simply shifted the drug of choice towards other more easily misused opioids, suggesting that a change in formulation alone will not be sufficient in controlling the epidemic. To control prescription opioid misuse requires treating populations with opioid use disorder and preventing the development of opioid abuse or dependence in unaffected populations. Buprenorphine with naloxone has been designed as an abuse-deterrent formulation, while also demonstrating significant efficacy in treating opioid use disorder. Thus, the dissemination of buprenorphine treatment can be a helpful step in reducing the current epidemic. Other strategies to reduce the epidemic include limiting the availability of leftover prescription opioids through drug take back programs, monitoring physician prescriptions through state prescription monitoring programs, and implementing evidence-based practices in pain management. Increased referral of patients with chronic nonmalignant pain to comprehensive pain rehabilitation programs can also reduce healthcare utilization while improving patient outcomes. Also, routine screening for prescription misuse and referral for addictions treatment must become a standard practice in order to ensure patient safety and create early opportunities for intervention. © 2015, Springer International Publishing AG (outside the USA).
引用
收藏
页码:122 / 135
页数:13
相关论文
共 50 条
  • [41] Avoiding globalisation of the prescription opioid epidemic
    Humphreys, Keith
    LANCET, 2017, 390 (10093): : 437 - 439
  • [42] Preventing a prescription opioid epidemic in Switzerland
    Ballantyne, Jane C.
    PAIN, 2024, 165 (01) : 1 - 2
  • [43] Mobilizing nurses to address the opioid misuse epidemic*
    Renda, Susan
    Eshkevari, Ladan
    Glymph, Derrick
    Knestrick, Joyce
    Lundy, Karen Saucier
    Ortiz, Mario
    Sharp, Daryl
    Solari-Twadell, Phyllis Ann
    Valentine, Nancy M.
    NURSING OUTLOOK, 2023, 71 (06)
  • [44] USING PRESCRIPTION DRUG MONITORING DATA TO PREDICT PRESCRIPTION OPIOID MISUSE
    Levin, Deysia
    Paone, Denise
    Tuazon, Ellenie
    Goldmann, Emily
    Martins, Silvia
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 : S170 - S170
  • [45] Prescription Medication Obtainment Methods and Misuse
    Bouland, Daniel Tyler
    Fine, Eric
    Withers, David
    Jarvis, Margaret
    JOURNAL OF ADDICTION MEDICINE, 2015, 9 (04) : 281 - 285
  • [46] Opioid management of pain: the impact of the prescription opioid abuse epidemic
    Rauenzahn, Sherri
    Del Fabbro, Egidio
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2014, 8 (03) : 273 - 278
  • [47] Prescription opioid medication misuse among university students
    Harries, Michael D.
    Lust, Katherine
    Christenson, Gary A.
    Redden, Sarah A.
    Grant, Jon E.
    AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (08): : 618 - 624
  • [48] Barriers to accurately assessing prescription opioid misuse on surveys
    Palamar, Joseph J.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (02): : 117 - 123
  • [49] Prescription Opioid Misuse Motives in US Older Adults
    Schepis, Ty S.
    Wastila, Linda
    Ammerman, Beth
    McCabe, Vita V.
    McCabe, Sean Esteban
    PAIN MEDICINE, 2020, 21 (10) : 2237 - 2243
  • [50] Prescription Opioid Misuse and Public Health Approach in Australia
    Kovitwanichkanont, Tom
    Day, Carolyn A.
    SUBSTANCE USE & MISUSE, 2018, 53 (02) : 200 - 205